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Mesenchymal stem cells (MSCs) are attracting growing interest by the scientific
community due to their huge regenerative potential. Thus, the plasticity of MSCs strongly
suggests the utilization of these cells for regenerative medicine applications. The main
issue about the clinical use of MSCs is related to the complex way to obtain them
from healthy tissues; this topic has encouraged scientists to search for novel and more
advantageous sources of these cells in easily accessible tissues. The oral cavity hosts
several cell populations expressing mesenchymal stem cell like-features, furthermore, the
access to oral and dental tissues is simple and isolation of cells is very efficient. Thus,
oral-derived stem cells are highly attractive for clinical purposes. In this context, human
periapical cyst mesenchymal stem cells (hPCy-MSCs) exhibit characteristics similar to
other dental-derived MSCs, including their extensive proliferative potential, cell surface
marker profile and the ability to differentiate into various cell types such as osteoblasts,
adipocytes and neurons. Importantly, hPCy-MSCs are easily collected from the surgically
removed periapical cysts; this reusing of biological waste guarantees a smart source of
stem cells without any impact on the surrounding healthy tissues. In this review, we report
themost interesting research topics related to hPCy-MSCswith a newsworthy discussion
about the future insights. This newly discovered cell population exhibits interesting and
valuable potentialities that could be of high impact in the future regenerative medicine
applications.
Keywords: mesenchymal stem cells (MSCs), human periapical cyst mesenchymal stem cells (hPCy-MSCs), cell
therapy, waste medicine, regenerative medicine
INTRODUCTION
Stem cell therapy has reached a central role in the regenerative medicine scenario with numerous
examples of translational applications reported in clinical trials designed for the most various
pathological conditions.
The first lineage of adult stem cells was discovered in bone marrow, such bone marrow-derived
cells were hematopoietic progenitors capable to reconstitute the entire blood system in
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immunocompromised hosts (Till and Ea, 1961). A few years
later, Friedenstein first described a population of “clonal,
plastic-adherent cells” residing in the same anatomical place
(Friedenstein et al., 1968). These newly discovered cells, similar to
hematopoietic stem cells, were able to self-renew, and moreover
possessed the ability to differentiate into cells of mesodermal
origin such as adipocytes, osteoblasts and chondrocytes. This
population was named “mesenchymal stem cells” (MSCs) and
was phenotypically defined by the expression of specific surface
markers such as CD105, CD90, CD73, and by the lacking of
markers typically expressed by hematopoietic cells including
HLA-DR, CD45, and CD34 (Barry and Murphy, 2004).
Bone marrow was initially considered the main source of
MSCs. Afterwards, several authors demonstrated that MSCs are
present in different human tissues such as blood, umbilical
cord, placenta, fat, heart, brain, skin, muscle, liver, gonads, and
teeth (Chamberlain et al., 2007; Egusa et al., 2012). Importantly,
human umbilical cord (UC), placenta and adipose tissue are
promising sources of mesenchymal stem cells. Umbilical cord
mesenchymal stem cells (UC-MSCs) are easily obtained fromUC
without ethical implications and exhibit excellent multipotency
(Van Pham et al., 2016). Human placental MSCs (PL-MSCs)
display the capability of multipotential differentiation and retain
a strong immunosuppressive potential (Chen et al., 2015).
Adipose tissue is an optimal source of proliferating, non-
immunogenic, and easily available stem cells (ASCs). This
population presents an intense paracrine activity that is able to
induce strong biological effects on surrounding cells such as the
promotion of cell proliferation and differentiation, as well as the
activation of reparative and regenerative mechanisms (Paduano
et al., 2017b). Furthermore, several studies demonstrated that
MSCs can differentiate toward several cell lineages and can
contribute to regeneration/reparation of a wide range of the adult
tissues including skeletal muscles, tendons, and neuronal cells,
demonstrating that MSCs hold an amazing plasticity (Phinney
and Isakova, 2005; Catacchio et al., 2013). The capability of MSCs
to differentiate into several cell types, as well as their important
immunomodulatory effects, make them an attractive therapeutic
tool for regenerative medicine, including cell transplantation and
tissue engineering.
Moreover, the immunomodulatory and restorative effects of
MSCs have been exploited for regenerative therapy in oncologic
patients after tumor ablative techniques. However, the paracrine
pro-angiogenic, anti-apoptotic, and pro-survival properties of
MSCs have been implicated by different studies as the possible
triggering of cancer recurrence (Zimmerlin et al., 2013). Another
study described the inhibition of tumor growth exerted by MSCs
through the down-regulation of survival signaling such as Wnt
and Akt pathways. It is known that MSCs have the ability to
migrate and engraft into tumor sites, but the real effect on cancer
growth/inhibition still remains a subject of debate (Hong et al.,
2014).
Collection of MSCs from human bone marrow (hBM) does
not imply a quite simple procedure, indeed, donorsmust undergo
an invasive surgery to allow the proper aspiration of bonemarrow
from the iliac crests. Moreover, cells obtained from hBM are in a
limited number, estimated to be nearly of one MSC per 34,000
nucleated cells (Beyer Nardi and da Silva Meirelles, 2006). These
issues have attracted the interest of researchers that are aiming
to search for alternative sources of MSCs that can be obtained
without the use of invasive and painful procedures.
ORAL DERIVED STEM CELLS
In the last years, several research groups have carefully analyzed
the oral and dental tissues as potential sources of MSCs. Oral-
derived stem cells (ODSCs) can be easily isolated from fresh teeth
extracted because of orthodontic or periodontal reasons. The
great accessibility to the oral tissues and the high abundance of
MSC-like cells in such anatomical district (Tatullo et al., 2015c)
have led ODSCs to be one the most studied type of MSCs.
During the last decades, it has been commonly hypothesized
that teeth develop their structure from two different embryonic
tissues: ectodermal epithelium and ectomesenchymal neural
crests, giving rise to specific tissues like pulp and dentine
(Koussoulakou et al., 2009). Using a mouse model of tooth
organogenesis, Kaukua et al. showed that a significant MSCs
population, highly active in dental tissue repairing, were derived
from peripheral nerve-associated glia. Thus, supporting the idea
that pulp cells and odontoblasts are generated from multipotent
mesenchymal progenitors originated by glial cells (Kaukua et al.,
2014).
In 2000, Gronthos et al. first described the existence of cells
in adult human dental pulp that are capable of self-renewal
and called these cells as dental pulp stem cells (DPSCs). Such
cells were also able to differentiate toward dentin/pulp-like
tissues after transplantation into immunocompromised mice.
Importantly, DPSCs possess the same immunophenotype of
bone marrow stromal cells (BMSCs) (Gronthos et al., 2000;
Figure 1). DPSCs have been largely investigated; they are adult
stem cells showing an optimal plasticity, indeed, they are able to
differentiate into the three mesenchymal cell lineages (osteocytes,
chondrocytes, and adipocytes) as well as into hepatocytes
(Ishkitiev et al., 2010), myocytes (Yang et al., 2010), neurons
(Iohara et al., 2006), and hair follicle cells (Reynolds and Jahoda,
2004).
Few years after the discovery of DPSCs, Miura and colleagues
isolated multipotent, clonogenic, and highly proliferating cells
from human exfoliated deciduous teeth (SHEDs); these cells
showed the ability to differentiate into various cell types, also
promoting the formation of dentin and bone tissues in vivo
(Miura et al., 2003).
Moreover, a cell population expressing mesenchymal stem
cell-like markers was found in periodontal ligament (PDL).
Periodontal ligament stem cells (PDLSCs) can differentiate into
adipocytes, collagen-forming cells, and cementoblast-like cells.
Importantly, these cells have been successfully used to regenerate
both cementum and PDL in animal models (Seo et al., 2004).
Developing teeth are covered by a thick connective tissue,
defined as dental follicle, containing MSCs called dental follicle
progenitor cells (DFPCs). These cells were first isolated by
Morsczeck et al. (2005) in the literature, such cells have been
described to promote neural regeneration as well as to regenerate
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FIGURE 1 | Mesenchymal stem cells isolated from oral tissues. Chronologic flow. DPSCs, dental pulp stem cells; SHEDs, stem cells from human exfoliated deciduous
teeth; PDLSCs, periodontal ligament stem cells; SCAPs, stem cells from apical papilla; hPCy-MSCs, human periapical cyst-mesenchymal stem cells.
periodontal and bone tissues (Morsczeck et al., 2005). Moreover,
also root apical papilla of human teeth was found to be rich
in stem cells. These cells known as stem cells from apical
papilla (SCAP) can differentiate into osteogenic and odontogenic
progenitors (Sonoyama et al., 2006; Yang et al., 2017).
Gingival tissues have been shown to be colonized by
multipotent clonogenic stem and progenitor cells. Gingiva-
derived MSCs have a clear regenerative potential comparable
to BMSCs (Tomar et al., 2010). Moreover, also the periosteum
covering the jawbones was identified as a source of MSC-
like cells able to differentiate into chondrocytes and osteoblasts
(Hutmacher and Sittinger, 2003).
Few researches have been also focused on human parotid
glands: surprisingly, such tissues contain cells expressing both
epithelial and mesenchymal specific markers and these cells are
able to form colonies, under specific culturing conditions (Yi
et al., 2016).
In 2013, Marrelli et al. discovered a new source of MSCs of
dental origin; they demonstrated for the first time the presence
of MSCs in human periapical cysts, which were termed human
periapical cyst-mesenchymal stem cells (hPCy-MSCs) (Marrelli
et al., 2013).
HUMAN PERIAPICAL
CYST-MESENCHYMAL STEM CELLS
Endodontic infections could lead to the formation of fibrous
inflammatory tissues, richly infiltrated by macrophages,
neutrophils and lymphocytes in the periapical area, with a
consequent onset of apical periodontitis; the chronicization of
such inflammatory condition may evolve into periapical cysts
formation (Nair, 2004).
Clinical observations showed the formation of new bone in
that periosteum area after surgical removal of periapical cyst,
suggesting that stem cells could be involved in the regenerative
process. A previous work reported by Maeda introduced
the hypothetical occurrence of osteogenic cells in periapical
granulation tissue (Maeda et al., 2004). After this first study, Patel
and Liao described the presence of mesenchymal stem cell-like
cells in granulation tissue, characterized by an intense osteogenic
commitment (Patel et al., 2010; Liao et al., 2011).
In the light of these preliminary studies, periapical cysts were
further investigated for the presence of MSCs: Marrelli et al.
isolated and fully characterized a new cell population named
hPCy-MSCs that could be considered one of the most promising
MSCs in the tissue regeneration landscape.
hPCy-MSCs: ISOLATION AND
CHARACTERIZATION
hPCy-MSCs isolation starts with a mechanical disruption of
the cystic wall obtained after surgery, with a sterile scalpel in
phosphate-buffered saline (PBS) solution containing antibiotics.
Then, periapical cystic tissue samples can be minced into
small pieces and subjected to enzymatic digestion with type-I
collagenase and dispase. Subsequently, samples can be filtered
and seeded in culture medium added with fetal bovine serum
(FBS) (Huang et al., 2006). Freshly isolated hPCy-MSCs have
a fibroblast-like morphology and can be plated up to 20
passages without losing their characteristics. Importantly, hPCy-
MSCs possess stem-cell-like properties, including extensive
proliferative potential, self-renewal capacity, and multi-lineage
differentiation ability (Marrelli et al., 2013).
Freshly collected hPCy-MSCs, similar to other types of dental-
derived MSCs such as DPSCs, DFPCs, and PDLSCs (Table 1),
highly express CD13, CD29, CD44, CD73, CD90, CD105, STRO-
1, and CD146 with a physiological variability among samples; in
addition, these cells do not express hematopoietic markers, such
as CD45 (Paduano et al., 2016a). Paduano et al. demonstrated the
central role of the cell adhesion receptor CD146 in influencing
hPCy-MSCs properties. In this work, the authors isolated
two populations expressing low and high levels of CD146
and demonstrated how the CD146low population displayed
an increased proliferative and clonogenic potential, showing
increased levels of the stemness gene marker KLF4; furthermore,
CD146low population had higher osteogenic potential compared
to CD146high cells (Paduano et al., 2016a).
LINEAGE COMMITMENTS OF hPCy-MSCs
hPCy-MSCs possess the classic trilineage differentiation potential
into osteogenic, adipogenic, and chondrogenic lineages (Marrelli
et al., 2013).
hPCy-MSCs after about 3 weeks of culturing in osteogenic
medium, showed the formation of calcium-based nodules
intensely positive to alizarin red staining, indicating the
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TABLE 1 | Comparative analysis of the expression of MSC-surface markers in
four cell types of dental-derived MSCs.
hPCy-MSCs DPSCs DFPCs PDLSCs
CD13 +++ +++ +++ +++
CD29 +++ +++ +++ +++
CD44 +++ +++ +++ +++
CD73 +++ +++ +++ +++
CD45 – – – –
CD90 +++ +++ +++ +++
CD105 +++ +++ +++ +++
CD146 ++ ++ + +++
Flow cytometry analysis of common MSCmarkers. Expression pattern of MSC markers in
hPCy-MSCs, human periapical cyst-mesenchymal stem cells; DPSCs, dental pulp stem
cells; DFPCs, dental follicle stem cells; PDLSCs, periodontal ligament stem cells at early
passages after isolation. + + +, ++, +, and – indicate high, moderate, low, and absent
expression of MSC surface marker, respectively (Paduano et al., 2016a).
osteogenic differentiation potential of hPCy-MSCs (Marrelli
et al., 2013). In addition, the mRNA levels of bone specific-
genes, such as osteopontin (OPN), osteocalcin (OSC), alkaline
phosphatase, and dentin matrix protein 1 (DMP-1) increased
after osteogenic induction (Marrelli et al., 2013). Importantly,
the same authors observed that, when compared to DPSCs
under the same conditions, hPCy-MSCs are preferably directed
toward osteogenesis whereas DPSCs were preferentially oriented
toward dentinogenesis (Tatullo et al., 2015a). qRT-PCR analyses
further revealed differences in the gene expression pattern
among these two populations. The expression levels of dentin
sialophosphoprotein (DSPP) and DMP-1 genes were increased
in DPSCs with respect to hPCy-MSCs, whereas osteonectin
(ON), bone sialoprotein (BSP), and runt-related transcription
factor 2 (RUNX-2) were highly expressed in hPCy-MSCs
compared to DPSCs (Tatullo et al., 2015a). In vivo studies
already confirmed the formation of mineralized tissues after
subcutaneous transplantation of periapical granulation tissue
derived-cells into NOD.CB17-Prkdcscid/J mice (Liao et al., 2011).
Furthermore, hPCy-MSCs seeded in adipogenic media can
form cytosolic lipid droplets that positively stain to oil
red, indicating the adipogenic differentiation potential of
hPCy-MSCs. qPCR investigations confirmed the augmented
expression of adipose-specific genes including: lipoprotein lipase
(LPL), adiponectin (ADIPOQ), peroxisome proliferator-activated
receptor gamma (PPARγ ), and glucose transporter type 4
(GLUT4) (Marrelli et al., 2013; Table 2).
To further confirm the multi-lineage differentiation capacity
of these cells, the same author showed that hPCys-MSCs were
able to effectively differentiate into neurogenic-like cells as
revealed by the immunofluorescence, western blotting, and flow
cytometry assays. Interestingly, they observed that the basal
expression levels of neuronal and astrocyte-specific proteins (β-
III tubulin and GFAP) in hPCys-MSCs were similar to those
of DPSCs. Moreover, qRT-PCR analysis under basal culturing
condition revealed higher levels of transcripts for neural-
related genes (β-III tubulin, microtubule associated protein
2), neural-related transcription factors (msh homeobox 1,
TABLE 2 | Comparative expression of differentiation markers in dental pulp stem
cells and hPCy-MSCs.
Osteogenic Adipogenic Neurogenic References
DPSCs OSC, ON, OPN,
BSP, DSPP,
RUNX-2, DMP-1
PPARγ, LPL GFAP, β-III
tubulin, NF-H,
NF-M, Nestin,
MAP2, NSE,
MSX-1, Pitx3,
Foxa2, Nurr1,
EN1, TH, DAT
Gronthos
et al., 2002;
Marrelli et al.,
2015b; Tatullo
et al., 2015a
hPCy-
MSCs
OSC, ON, OPN,
BSP, DSPP,
RUNX-2, DMP-1
GLUT4, LPL,
ADIPOQ, PPARγ
GFAP, β-III
tubulin, NF-H,
NF-M, Nestin,
MAP2, NSE,
MSX-1, Pitx3,
Foxa2, Nurr1,
EN1, TH, DAT
Marrelli et al.,
2013, 2015b;
Tatullo et al.,
2015a
OSC, Osteocalcin; ON, osteonectin; OPN, osteopontin; BSP, bone sialoprotein; DSPP,
dentin sialophosphoprotein; RUNX-2, runt-related transcription factor 2; DMP-1, dentin
matrix protein 1; GLUT4, glucose transporter type 4; LPL, lipoprotein lipase; ADIPOQ,
adiponectin; PPARγ, peroxisome proliferator-activated receptor gamma; LPL, lipoprotein
lipase; NF-H, neurofilaments heavy; NF-M, neurofilaments medium; NSE, neuronspecific
enolase; MSX1, Msh homeobox 1; MAP2, microtubule associated protein 2; GFAP, glial
fibrillary acidic protein; PITX3, pituitary homeobox 3; NURR1, nuclear receptor related 1
protein; Foxa2, forkhead Box A2; EN1, engrailed homeobox 1; TH, tyrosine hydroxylase;
DAT, dopamine transporter.
forkhead box protein A2, engrailed homeobox 1) and for
dopamine-related genes (tyrosine hydroxylase and dopamine
transporter) in hPCy-MSCs than in DPSCs. Importantly, the
expression of neuronal markers were greatly increased under
neurogenic conditions (neural medium containing retinoic acid,
epidermal growth factor, and basic fibroblast growth factor).
Thus, hPCy-MSCs cultured under neurogenic medium are able
to acquire the typical neuron-like morphology, characterized
by the presence of dendrite and axonal structures (Marrelli
et al., 2015b). Taken together, these results showed that
hPCy-MSCs possess a multi-lineage differentiation potential
similar to that of other dental-derived MSCs such as DPSCs
(Table 2).
POTENTIAL CLINICAL APPLICATIONS OF
hPCy-MSCs
Mesenchymal stem cells play a key role in regenerative medicine;
after their discovery, MSCs were mainly collected from bone
marrow or adipose tissue, however, the surgical procedures
needed to collect such cells were invasive and often painful for
patients. Therefore, the scientific community is actively involved
in the discovering of alternative sources of MSCs. The oral cavity
is strongly populated by MSCs that could be easily isolated in a
minimally invasive way (Tatullo et al., 2015b). Thanks to their
plasticity, oral derived MSCs can differentiate toward a wide
range of specialized tissues, including fat, bone, cartilage, muscle,
tendon, and neural tissues (Rosenbaum et al., 2008). In addition,
oral derivedMSCs produce anti-inflammatory and trophic effects
by secreting several immunomodulatory molecules, supporting
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self-regulated healing processes in damaged tissues and providing
a regenerative microenvironment (Figueroa et al., 2012).
ODSCs attracted clinical interest first in the oral and
maxillofacial fields, as they have been recognized to be strategic
for a better regeneration of bone and dental tissues, such
as cementum, dentin and periodontal ligament. Many studies
supported this concept: Seo et al. showed the ability of
ODSCs to produce cementum and periodontal ligament after
transplantation of human PDLSCs into immunocompromised
mice (Seo et al., 2004). Zhang et al. seeded DPSCs on different
scaffolds made of several materials including titanium, collagen,
and sintered ceramic and investigated cell proliferation and
differentiation on these scaffolds. As results, DPSCs were able to
grow onto different scaffolds, moreover, they differentiated into
osteocytes capable to generate a mineralized matrix (Zhang et al.,
2012).
Nanoporous and mesoporous silicon scaffolds efficiently
support DPSCs proliferation, thus they could represent a fine
substrate for these cells in tissue engineering procedures (Marrelli
et al., 2015a).
In the field of bone regeneration, hydrogel-based scaffolds can
be obtained from decellularized and demineralized bovine bone
extracellular matrix. Recent studies emphasized how ODSCs
could be easily and efficiently cultured on hydrogels (Cavalcanti
et al., 2013; Coyac et al., 2013) moreover, dental pulp stem cells
are able to spontaneously differentiate toward both odontogenic
(Paduano et al., 2016b) and osteogenic phenotype (Paduano et al.,
2017a) when cultured on these scaffolds.
hPCy-MSCs have been reported to retain high proliferative
rate and extensive multipotency. These key properties play a
strategic role in bone and dental regeneration, even more if
hPCy-MSCs are added to specific scaffolds. Furthermore, the
recently discovered neural plasticity of these cells undoubtedly
represents a perspective feature to be further investigated for
future innovative strategies in brain repairing. In this light, stem
cell therapies for some widespread neurodegenerative diseases,
such as Alzheimer and Parkinson syndromes encountered many
ethical issues related to the use of embryonic stem cells (Lees
et al., 2009). Thus, many authors proposed alternative treatments
based on adult mesenchymal stem cells to regenerate injured
neural tissues (Uccelli et al., 2011).
In the last few years, researchers are carrying out
pioneering studies aimed to investigate the biochemical
pathways in cellular models of Parkinson’s disease. In this
context, the spontaneous commitment of hPCy-MSCs
to differentiate toward neuron-like cells arouses exciting
insights about new therapies involving hPCy-MSCs. Further
investigations are needed to evaluate the neuroregenerative
potential of these newly discovered ODSCs in animal models
(Figure 2).
CONCLUSIONS
Dental periapical cysts are certainly among the most common
lesions discovered after the observation of orthopanoramic
radiographies; these benign formations are surgically eradicated
FIGURE 2 | Clinical potentialities of hPCy-MSCs.
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by dentists to prevent the development of more severe
pathologies, especially to the surrounding bone tissue.
Although inflamed cysts are routinely discarded as biological
waste, recent researches revealed a strategic role of this
granulation tissue (Liao et al., 2011), which represents a rich
source of stem cells obtainable without any biological cost for
patients.
The hypothesis reporting that biological wastes can be
considered as resources for new unexpected biological
applications have been largely discussed in the scientific
literature, even in areas far from human biology, but closer
to food biotechnology. For example, a recent study reported
the extraction of bioactive compounds from food waste for
pharmaceutical and medical purposes (Tatullo et al., 2016). Thus,
many research topics perfectly fit with the need to use economic
sources for medical applications. Periapical cysts fully reflect the
modern concept of biological waste medicine, where rejected
surgical tissues are exploited as precious fonts for novel medical
applications (Tatullo, 2017).
Sources of abundant and highly immature MSCs, obtained
from easily available and “biologically cheap” tissues,
undoubtedly represent an extremely interesting and important
finding. In this context, hPCy-MSCs, similarly to DPSCs, could
be considered as an optimal cell source for tissue engineering
applications. The use of human hPCy-MSCs is not free of
criticisms since the immunomodulatory properties of these cells
are not yet evaluated and most results were obtained from in
vitro experiments. Thus, the real challenge now is to translate
the in vitro results to an in vivo context, and therefore future
investigation should be carried out to confirm the in vivo
regenerative potential of these newly discovered MSCs.
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